These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 9704134

  • 1. [Renal function during water-salt depletion. Effects of alpha-blocking treatment with prazosin].
    Agnoli GC, Cacciari M, Garutti C, Lenzi P.
    Boll Soc Ital Biol Sper; 1983 Mar 30; 59(3):349-55. PubMed ID: 9704134
    [No Abstract] [Full Text] [Related]

  • 2. [Adrenolytic drugs and the restoration of renal vasodilator and water-salt capacity of dopamine under water-salt deprivation conditions].
    Agnoli GC, Cacciari M, Garutti C, Lenzi P.
    Boll Soc Ital Biol Sper; 1983 Mar 30; 59(3):356-61. PubMed ID: 9704135
    [No Abstract] [Full Text] [Related]

  • 3. [Dependence of various methods of control of renal function on the water-salt content of the organism and on the level of activity of the adrenergic system].
    Agnoli GC, Cacciari M, Cocco G, Garutti C, Lenzi P.
    Boll Soc Ital Biol Sper; 1983 Mar 30; 59(3):362-8. PubMed ID: 9704136
    [No Abstract] [Full Text] [Related]

  • 4. Adrenergic blocking agents and the kidney.
    Bauer JH.
    J Clin Hypertens; 1985 Sep 30; 1(3):199-221. PubMed ID: 2872278
    [Abstract] [Full Text] [Related]

  • 5. [Extrinsic catecholaminergic control of the renal function during water and salt depletion].
    Agnoli GC, Cacciari M, Cocco G, Garutti C, Lenzi P.
    Arch Sci Med (Torino); 1983 Sep 30; 140(1):9-27. PubMed ID: 6307216
    [Abstract] [Full Text] [Related]

  • 6. [Further studies on the reactivity of renal catecholamine receptors in man in water-salt depletion].
    Agnoli GC, Borgatti R, Cacciari M, Dorigoni S, Garutti C, Ikonomu E, Lenzi P.
    Cardiologia; 1985 May 30; 30(5):387-94. PubMed ID: 3833351
    [No Abstract] [Full Text] [Related]

  • 7. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R.
    Nefrologia; 2008 May 30; 28 Suppl 3():87-93. PubMed ID: 19018744
    [Abstract] [Full Text] [Related]

  • 8. Involvement of central alpha1- and alpha2-adrenoceptors on cardiovascular responses to moxonidine.
    Moreira TS, Takakura AC, Menani JV, Colombari E.
    Eur J Pharmacol; 2007 Jun 01; 563(1-3):164-71. PubMed ID: 17382316
    [Abstract] [Full Text] [Related]

  • 9. Effects of prazosin therapy on BP, renal function, and body fluid composition.
    Bauer JH, Jones LB, Gaddy P.
    Arch Intern Med; 1984 Jun 01; 144(6):1196-200. PubMed ID: 6732379
    [Abstract] [Full Text] [Related]

  • 10. [Low-dose dopamine as an activator of renal catecholamine receptors of different classes. II. Studies in water-saline depletion and associated adrenergic blockade].
    Agnoli GC, Borgatti R, Cacciari M, Dorigoni S, Garutti C, Ikonomu E, Lenzi P.
    Boll Soc Ital Biol Sper; 1984 Oct 30; 60(10):1949-54. PubMed ID: 6097293
    [Abstract] [Full Text] [Related]

  • 11. alpha-Adrenoceptor subtypes mediating regional kidney blood flow responses to renal nerve stimulation.
    Eppel GA, Lee LL, Evans RG.
    Auton Neurosci; 2004 May 31; 112(1-2):15-24. PubMed ID: 15233926
    [Abstract] [Full Text] [Related]

  • 12. FK 506-induced nephrotoxicity in rats.
    Kumano K, Wang G, Endo T, Kuwao S.
    Transplant Proc; 1991 Feb 31; 23(1 Pt 1):512-5. PubMed ID: 1703696
    [No Abstract] [Full Text] [Related]

  • 13. [Suppression, by beta-adrenergic receptor blockade, of the sympathomimetic component of dopamine renal action in water-saline depletion].
    Agnoli GC, Cacciari M, Garutti C, Lenzi P.
    Boll Soc Ital Biol Sper; 1980 May 15; 56(9):946-52. PubMed ID: 6108775
    [Abstract] [Full Text] [Related]

  • 14. Adrenoreceptors and renal function.
    Wallin JD.
    J Clin Hypertens; 1985 Jun 15; 1(2):171-8. PubMed ID: 2873207
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Acute effects of intravenous cyclosporine on renal function in healthy humans.
    Weir MR, Klassen DK, Shen SY, Sullivan D, Buddemeyer EU, Handwerger BS.
    Transplant Proc; 1989 Feb 15; 21(1 Pt 1):915-7. PubMed ID: 2705255
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. 6,7-Dihydro-5-[[(cis-2-hydroxy-trans-3-phenoxycyclopentyl)amino] methyl]-2-methylbenzo[b]thiophen-4(5H)-one: a novel alpha 1-adrenergic receptor antagonist and renal vasodilator.
    McCarthy JR, Zimmerman MB, Trepanier DL, LeTourneau ME, Wiedeman PE, Whitten JP, Broersma RJ, Shea PJ, Wiech NL, Huffman JC.
    J Med Chem; 1985 Sep 15; 28(9):1142-5. PubMed ID: 2863377
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.